Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune condition, characterised by joint pain, damage and disability, which can be addressed in a high proportion of patients by timely use of targeted biologic treatments. However, the patients, non-responsive to the treatments often suffer from refractoriness of the disease, leading to poor quality of life. Additionally, the biologic treatments are expensive. We obtained plasma samples from N = 144 participants with RA, who were about to commence anti-tumour necrosis factor (anti-TNF) therapy. These samples were sent to Olink Proteomics, Uppsala, Sweden, where proximity extension assays of 4 panels, containing 92 proteins each, were performed. A total of n = 89 samples of patients passed the quality control of anti-TNF treatment response data. The preliminary analysis of plasma protein expression values suggested that the RA population could be divided into two distinct molecular sub-groups (endotypes). However, these broad groups did not predict response to anti-TNF treatment, but were significantly different in terms of gender and their disease activity. We then labelled these patients as responders (n = 60) and non-responders (n = 29) based on the change in disease activity score (DAS) after 6 months of anti-TNF treatment and applied machine learning (ML) with a rigorous 5-fold nested cross-validation scheme to filter 17 proteins that were significantly associated with the treatment response. We have developed a ML based classifier ATRPred (anti-TNF treatment response predictor), which can predict anti-TNF treatment response in RA patients with 81% accuracy, 75% sensitivity and 86% specificity. ATRPred may aid clinicians to direct anti-TNF therapy to patients most likely to receive benefit, thus save cost as well as prevent non-responsive patients from refractory consequences. ATRPred is implemented in R.
Funder
Vice-Chancellor’s Research Scholarship (VCRS), Ulster University
European Union Regional Development Fund
EU Sustainable Competitiveness Programme for Northern Ireland & the Northern Ireland Public Health Agency
Ulster University
Innovate UK NxNW ICURe programme
Publisher
Public Library of Science (PLoS)
Subject
Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modeling and Simulation,Ecology, Evolution, Behavior and Systematics
Reference68 articles.
1. Rheumatoid arthritis.;JS Smolen;Nat Rev Dis Primers,2018
2. Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors;D Mewar;Br J Pharmacol,2011
3. Loss of response to anti-TNFs: definition, epidemiology, and management.;G Roda;Clin Transl Gastroenterol,2016
4. Common characteristics in RA patients who don’t respond to biologics;V. Caceres;The Rheumatologist.,2019
5. Cytokines in rheumatoid arthritis—shaping the immunological landscape.;IB McInnes;Nat Rev Rheumatol,2016
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献